Previous Article | Next Article ![]()
J Virol, May 1998, p. 4250-4264, Vol. 72, No. 5
Division of Molecular Genetics, Dana-Farber
Cancer Institute and Department of Microbiology and Molecular
Genetics, Harvard Medical School, Boston, Massachusetts 02115
Received 1 December 1997/Accepted 15 January 1998
The herpes simplex virus type 1 L/S junction-spanning transcripts
(L/STs) are a family of multisized transcripts expressed at
high levels in cells infected with mutant viruses that (i) do not
express ICP4, (ii) specify forms of ICP4 unable to bind to the
consensus ICP4 binding site, or (iii) contain mutations in the ICP4
binding site located at the transcriptional start site of the L/STs. By
extension, the failure to detect the L/STs in wild-type virus-infected
cells is due to the repressive effect of ICP4 bound to its cognate
binding site upstream of the L/ST transcription initiation site. ORF-P,
the first and largest open reading frame (ORF) encoded by the L/STs,
overlaps >90% of the ORF encoding ORF-34.5, a putative neurovirulence
factor, which is transcribed from the opposite DNA strand. Viruses with
mutations in the overlapping region of ORF-P and ICP34.5 exhibit
premature shutoff of infected-cell protein synthesis and are highly
attenuated following intracranial inoculation of juvenile mice. To
determine whether the premature protein shutoff and neuroattenuated
phenotypes of ORF-P ORF-34.5 double mutants are a consequence of
alterations in ORF-P, ORF-34.5, or both, viruses
containing mutations only in ORF-P or only in the ICP4
binding site in the L/ST promoter were isolated and
characterized. Mutant virus L/ST-n38 contains a
single-base-pair transition mutation in ORF-P codon 38, resulting in
translational termination of the ORF-P protein (OPP). This mutation
does not alter the amino acid sequence of ICP34.5. Expression of a
truncated form of OPP by mutant virus L/ST-n38 did not
result in premature shutoff of infected-cell protein synthesis and
produced no other observable phenotype relative to wild-type
virus in in vitro tests. Moreover, the 50% lethal dose
(LD50) of L/ST-n38 was comparable to that of
wild-type virus following intracranial inoculation of 3-week-old mice,
as were the latency and reactivation phenotypes of the virus. These
properties of L/ST-n38 indicate that the attenuated
phenotype of ORF-P ORF-34.5 double mutants is a consequence of
mutations that affect the function of ICP34.5 and not the function of
OPP. Mutant virus L/ST-4BS contains four single-base-pair substitutions
in the ICP4 binding site in the L/ST promoter that abrogate the binding
of ICP4 to this site, leading to high-level expression of the L/STs and
OPP. L/ST-4BS induced premature shutoff of viral and cellular protein
synthesis and was slightly growth restricted in cells of neural lineage (SK-N-SH human neuroblastoma cells) but was wild type for these two
parameters in cells of nonneural lineage (immortalized primate Vero
cells). Of particular interest was the observation that L/ST-4BS exhibited cell-type-specific expression of both the
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
A Virus with a Mutation in the ICP4-Binding Site in the L/ST
Promoter of Herpes Simplex Virus Type 1, but Not a Virus with a
Mutation in Open Reading Frame P, Exhibits Cell-Type-Specific
Expression of
134.5 Transcripts and
Latency-Associated Transcripts
134.5 transcripts and the latency-associated
transcripts (LATs). Thus, expression of these transcripts was
barely detectable in cells of neural lineage (NB41A3 mouse
neuroblastoma cells) but was wild type in Vero cells. In vivo, L/ST-4BS
was reactivated from mouse trigeminal ganglia with reduced efficiency
and delayed kinetics relative to wild-type virus. L/ST-4BS was
completely attenuated for neurovirulence (LD50 > 106 PFU) relative to wild-type virus (LD50 < 900 PFU), although the four single-base-pair substitutions lie outside
the coding region for the neurovirulence factor, ICP34.5. Collectively,
the complex in vitro and in vivo phenotypes of L/ST-4BS can be
attributed to (i) disruptions of the ICP4 binding site in the L/ST
promoter and subsequent overexpression of the L/STs and OPP; (ii)
alterations in ORF-O, which is also mutated in L/ST-4BS; or (iii)
alterations in other cryptic genes or cis-acting elements.
*
Corresponding author. Mailing address: Department of
Microbiology, University of Pennsylvania School of Medicine, 225A
Johnson Pavilion, 3610 Hamilton Walk, Philadelphia, PA 19104-6067. Phone: (215) 573-9863. Fax: (215) 573-5344. E-mail:
pschfr{at}mail.med.upenn.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|